RBMS3 and lung carcinoma: RBMS3 has been shown to reduce EMT and metastatic capacity of lung cancer cells (Liang et al. 2015) and reduces EMT in gastric cancer cells through suppression of canonical Wnt signaling (Yang et al. 2018).